Development of a Pentacistronic Ebola Virus Minigenome System

Ebola virus (EBOV) causes severe disease outbreaks in humans with high case fatality rates. EBOV requires adaptation to cause lethal disease in mice by acquiring single mutations in both the nucleoprotein (NP) and VP24 genes. As an attempt to model mouse-adapted EBOV (MA-EBOV), we engineered novel pentacistronic minigenomes (5xMG) containing a reporter gene, VP40, and glycoprotein genes as well as the NP and VP24 genes from either EBOV or MA-EBOV. The 5xMGs were constructed and optimized, and the produced transcription- and replication-competent virus-like particles (trVLPs) were demonstrated to infect several cell lines. Introduction of the mouse-adaptation mutations did not significantly impact the replication and transcription of the 5xMG or the relative infectivity of the trVLPs in vitro. This work demonstrates the development of the 5xMG system as a new versatile tool to study EBOV biology.

Authors

Institutions

Publication Details

Journal
Viruses
Published
2025-05-09
DOI
https://doi.org/10.3390/v17050688
Citations
1
Primary Topic
Viral Infections and Outbreaks Research
Type
article
Field-Weighted Citation Impact
1.40

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Development of a Pentacistronic Ebola Virus Minigenome System

Satoko Yamaoka, Brady N. Zell, Hideki Ebihara, Vaille A. Swenson et al.
1 citations
Viruses
Viral Infections and Outbreaks Research
1.40
article

Development of a Pentacistronic Ebola Virus Minigenome System

Satoko Yamaoka, Brady N. Zell, Hideki Ebihara, Vaille A. Swenson, Michael A. Barry, Shao‐Chia Lu, Lin Wang
article en
1 citations

Abstract

Ebola virus (EBOV) causes severe disease outbreaks in humans with high case fatality rates. EBOV requires adaptation to cause lethal disease in mice by acquiring single mutations in both the nucleoprotein (NP) and VP24 genes. As an attempt to model mouse-adapted EBOV (MA-EBOV), we engineered novel pentacistronic minigenomes (5xMG) containing a reporter gene, VP40, and glycoprotein genes as well as the NP and VP24 genes from either EBOV or MA-EBOV. The 5xMGs were constructed and optimized, and the produced transcription- and replication-competent virus-like particles (trVLPs) were demonstrated to infect several cell lines. Introduction of the mouse-adaptation mutations did not significantly impact the replication and transcription of the 5xMG or the relative infectivity of the trVLPs in vitro. This work demonstrates the development of the 5xMG system as a new versatile tool to study EBOV biology.

VirusesVol. 17(5)
Mayo Clinic (US), WinnMed (US), National Institute of Infectious Diseases (JP), Mayo Clinic in Florida (US)
National Institutes of Health, National Institute of Allergy and Infectious Diseases
Good health and well-being
Openalex Percentile: Top 21%
Viral Infections and Outbreaks Research
1.40
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Development of a Pentacistronic Ebola Virus Minigenome System — Satoko Yamaoka, Brady N. Zell, et al. · Viruses (2025) | TGRS Research Map | TGRS